Bruker Long Term Debt 2012-2026 | BRKR
Bruker long term debt from 2012 to 2026. Long term debt can be defined as the sum of all long term debt fields.
- Bruker long term debt for the quarter ending March 31, 2026 was $1.984B, a 12.38% decline year-over-year.
- Bruker long term debt for 2024 was $2.062B, a 77.7% increase from 2023.
- Bruker long term debt for 2023 was $1.16B, a 3.35% decline from 2022.
- Bruker long term debt for 2022 was $1.201B, a 1.74% decline from 2021.
|
Bruker Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $2,062 |
| 2023 | $1,160 |
| 2022 | $1,201 |
| 2021 | $1,222 |
| 2020 | $842 |
| 2019 | $813 |
| 2018 | $323 |
| 2017 | $416 |
| 2016 | $392 |
| 2015 | $265 |
| 2014 | $354 |
| 2013 | $354 |
| 2012 | $336 |
| 2011 | $219 |
|
Bruker Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-09-30 | $1,984 |
| 2025-06-30 | $2,380 |
| 2025-03-31 | $2,076 |
| 2024-12-31 | $2,062 |
| 2024-09-30 | $2,265 |
| 2024-06-30 | $2,132 |
| 2024-03-31 | $1,357 |
| 2023-12-31 | $1,160 |
| 2023-09-30 | $1,099 |
| 2023-06-30 | $1,123 |
| 2023-03-31 | $1,109 |
| 2022-12-31 | $1,201 |
| 2022-09-30 | $1,137 |
| 2022-06-30 | $1,171 |
| 2022-03-31 | $1,205 |
| 2021-12-31 | $1,222 |
| 2021-09-30 | $718 |
| 2021-06-30 | $721 |
| 2021-03-31 | $716 |
| 2020-12-31 | $842 |
| 2020-09-30 | $828 |
| 2020-06-30 | $924 |
| 2020-03-31 | $915 |
| 2019-12-31 | $813 |
| 2019-09-30 | $519 |
| 2019-06-30 | $494 |
| 2019-03-31 | $332 |
| 2018-12-31 | $323 |
| 2018-09-30 | $225 |
| 2018-06-30 | $206 |
| 2018-03-31 | $206 |
| 2017-12-31 | $416 |
| 2017-09-30 | $481 |
| 2017-06-30 | $431 |
| 2017-03-31 | $385 |
| 2016-12-31 | $392 |
| 2016-09-30 | $345 |
| 2016-06-30 | $323 |
| 2016-03-31 | $282 |
| 2015-12-31 | $265 |
| 2015-09-30 | $241 |
| 2015-06-30 | $241 |
| 2015-03-31 | $354 |
| 2014-12-31 | $354 |
| 2014-09-30 | $355 |
| 2014-06-30 | $355 |
| 2014-03-31 | $354 |
| 2013-12-31 | $354 |
| 2013-09-30 | $355 |
| 2013-06-30 | $335 |
| 2013-03-31 | $336 |
| 2012-12-31 | $336 |
| 2012-09-30 | $298 |
| 2012-06-30 | $243 |
| 2012-03-31 | $243 |
| 2011-12-31 | $219 |
| 2011-09-30 | $41 |
| 2011-06-30 | $60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |